International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases
MetadataShow full item record
© 2017 The Author(s) Provision of a molecularly confirmed diagnosis in a timely manner for children and adults with rare genetic diseases shortens their “diagnostic odyssey,” improves disease management, and fosters genetic counseling with respect to recurrence risks while assuring reproductive choices. In a general clinical genetics setting, the current diagnostic rate is approximately 50%, but for those who do not receive a molecular diagnosis after the initial genetics evaluation, that rate is much lower. Diagnostic success for these more challenging affected individuals depends to a large extent on progress in the discovery of genes associated with, and mechanisms underlying, rare diseases. Thus, continued research is required for moving toward a more complete catalog of disease-related genes and variants. The International Rare Diseases Research Consortium (IRDiRC) was established in 2011 to bring together researchers and organizations invested in rare disease research to develop a means of achieving molecular diagnosis for all rare diseases. Here, we review the current and future bottlenecks to gene discovery and suggest strategies for enabling progress in this regard. Each successful discovery will define potential diagnostic, preventive, and therapeutic opportunities for the corresponding rare disease, enabling precision medicine for this patient population.
Showing items related by title, author, creator and subject.
Lochmüller, H.; TorrentFarnell, J.; Le Cam, Y.; Jonker, A.; Lau, L.; Baynam, Gareth; Kaufmann, P.; Dawkins, Hugh; Lasko, P.; Austin, C.; Boycott, K. (2017)© 2017 European Society of Human Genetics. The International Rare Diseases Research Consortium (IRDiRC) has agreed on IRDiRC Policies and Guidelines, following extensive deliberations and discussions in 2012 and 2013, as ...
Molster, C.; Urwin, D.; Di Pietro, L.; Fookes, M.; Petrie, D.; van der Laan, S.; Dawkins, Hugh (2016)Background: Few studies have examined whether the healthcare needs of people living with rare diseases are being met. This study explores the experiences of Australian adults living with rare diseases in relation to ...
Improved diagnosis and care for rare diseases through implementation of precision public health frameworkBaynam, Gareth; Bowman, F.; Lister, K.; Walker, C.; Pachter, N.; Goldblatt, J.; Boycott, K.; Gahl, W.; Kosaki, K.; Adachi, T.; Ishii, K.; Mahede, T.; McKenzie, Fiona; Townshend, S.; Slee, J.; Kiraly-Borri, C.; Vasudevan, A.; Hawkins, A.; Broley, S.; Schofield, L.; Verhoef, H.; Groza, T.; Zankl, A.; Robinson, P.; Haendel, M.; Brudno, M.; Mattick, J.; Dinger, M.; Roscioli, T.; Cowley, M.; Olry, A.; Hanauer, M.; Alkuraya, F.; Taruscio, D.; Posada De La Paz, M.; Lochmüller, H.; Bushby, K.; Thompson, R.; Hedley, V.; Lasko, P.; Mina, K.; Beilby, J.; Tifft, C.; Davis, M.; Laing, N.; Julkowska, D.; Le Cam, Y.; Terry, S.; Kaufmann, P.; Eerola, I.; Norstedt, I.; Rath, A.; Suematsu, M.; Groft, S.; Austin, C.; Draghia-Akli, R.; Weeramanthri, Tarun; Molster, C.; Dawkins, Hugh (2017)© Springer International Publishing AG 2017. Public health relies on technologies to produce and analyse data, as well as effectively develop and implement policies and practices. An example is the public health practice ...